After 18 - 24 months , in terms of treatment failure , the odds ratio for calcium hydroxide vs. formocresol was 1.94 [ 95 % credible interval ( CI ) : 1.11 , 3.25 ] ; 3.38 ( 95 % CI : 1.37 , 8.61 ) for lasers vs. formocresol ; 2.16 ( 95 % CI : 1.12 , 4.31 ) for calcium hydroxide vs. ferric sulfate ; 3.73 ( 95 % CI : 1.27 , 11.67 ) for lasers vs. ferric sulfate ; 0.47 ( 95 % CI : 0.26 , 0.83 ) for MTA vs. calcium hydroxide ; 3.76 ( 95 % CI : 1.39 , 10.08 ) for lasers vs. MTA CONCLUSIONS After 18 - 24 months , formocresol , ferric sulfate , and MTA showed significantly better clinical and radiographic outcomes than calcium hydroxide and laser therapies in primary molar pulpotomies .
CLINICAL SIGNIFICANCE The network meta-analyses showed that MTA is the first choice for primary molar pulpotomies .
However , if treatment cost is an issue , especially when the treated primary molars are going to be replaced by permanent teeth , ferric sulfate may be the choice
OBJECTIVE Pulpotomy is a common procedure to treat asymptomatic reversible pulpitis in primary molars .
The aim of this study is to undertake a systematic review and a network meta- analysis to compare the clinical and radiographic outcomes of different pulpotomy procedures in primary molars .
Mineral trioxide aggregate produces superior outcomes in vital primary molar pulpotomy.
PURPOSE The purpose of this study was to investigate the outcomes of vital primary molar pulpotomy  when there is no direct contact between eugenol and the vital pulp . Four pulpotomy techniques were compared : ( 1 ) ferric sulfate ( FS ) pulpotomy ; ( 2 ) eugenol-free FS pulpotomy ; ( 3 ) mineral trioxide aggregate ( MTA ) pulpotomy ; and ( 4 ) FS/MTA pulpotomy . METHODS The pulpotomy technique assigned to each molar was determined by r and om selection . Two blinded , disinterested raters classified each molar into 1 of 3 radiographic outcomes : ( 1 ) N = normal molar without pathologic change ; ( 2 ) Po = pathologic change present , follow-up recommended ; ( 3 ) Px = pathologic change present , extract . RESULTS A total of 92 patients with 227 pulpotomy-treated molars returned for at least 1 recall examination . Median follow-up for molars was 24 months ( range=12 - 38 months ) . MTA molars demonstrated significantly fewer Px radiographic outcomes than FS molars ( P=.002 , chi-square test ) . Eugenol-free FS molars demonstrated significantly more Px radiographic outcomes than MTA ( P<.001 , chi-square test ) or FS/MTA ( P=.002 , chi-square test ) molars . Significantly lower survival was demonstrated for eugenol-free FS molars compared to MTA molars ( P=.02 , log-rank test ) over 6 to 38 months . CONCLUSIONS Outcomes for mineral trioxide aggregate pulpotomy were superior to ferric sulfate and eugenol-free ferric sulfate pulpotomy after a median follow-up of 2 years
After 18 - 24 months , in terms of treatment failure , the odds ratio for calcium hydroxide vs. formocresol was 1.94 [ 95 % credible interval ( CI ) : 1.11 , 3.25 ] ; 3.38 ( 95 % CI : 1.37 , 8.61 ) for lasers vs. formocresol ; 2.16 ( 95 % CI : 1.12 , 4.31 ) for calcium hydroxide vs. ferric sulfate ; 3.73 ( 95 % CI : 1.27 , 11.67 ) for lasers vs. ferric sulfate ; 0.47 ( 95 % CI : 0.26 , 0.83 ) for MTA vs. calcium hydroxide ; 3.76 ( 95 % CI : 1.39 , 10.08 ) for lasers vs. MTA CONCLUSIONS After 18 - 24 months , formocresol , ferric sulfate , and MTA showed significantly better clinical and radiographic outcomes than calcium hydroxide and laser therapies in primary molar pulpotomies .
CLINICAL SIGNIFICANCE The network meta-analyses showed that MTA is the first choice for primary molar pulpotomies .
However , if treatment cost is an issue , especially when the treated primary molars are going to be replaced by permanent teeth , ferric sulfate may be the choice
OBJECTIVE Pulpotomy is a common procedure to treat asymptomatic reversible pulpitis in primary molars .
The aim of this study is to undertake a systematic review and a network meta- analysis to compare the clinical and radiographic outcomes of different pulpotomy procedures in primary molars .